Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Publications from the Centre for Immuno-Oncology

The antibodies 3D12 and 4D12 recognise distinct epitopes and conformations of HLA-E

Journal article

Borrow P. et al, (2024), Frontiers in Immunology

Flexible and cost-effective genomic surveillance of P. falciparum malaria with targeted nanopore sequencing.

Journal article

de Cesare M. et al, (2024), Nature communications, 15

TCRs and AI: the future is now.

Journal article

Sim MJW., (2023), Nat Rev Immunol

Targeting mitotic regulators in cancer as a strategy to enhance immune recognition.

Journal article

Gregorczyk M. and Parkes EE., (2023), DNA repair, 132

Interferon-γ couples CD8+ T cell avidity and differentiation during infection.

Journal article

Uhl LFK. et al, (2023), Nature communications, 14

Innate receptors with high specificity for HLA class I-peptide complexes.

Journal article

Sim MJW. et al, (2023), Science immunology, 8

Nondestructively probing the thermodynamics of quantum systems with qumodes

Journal article

Elliott TJ. et al, (2023), AVS Quantum Science, 5

Inhibition of salt inducible kinases reduces rhythmic HIV-1 replication and reactivation from latency.

Journal article

Borrmann H. et al, (2023), The Journal of general virology, 104

Intracellular trafficking of HLA-E and its regulation.

Journal article

He W. et al, (2023), The Journal of experimental medicine, 220

Non-cell-autonomous cancer progression from chromosomal instability.

Journal article

Li J. et al, (2023), Nature, 620, 1080 - 1088

Reactivation of low avidity tumor-specific CD8+ T cells associates with immunotherapeutic efficacy of anti-PD-1.

Journal article

Sugiyarto G. et al, (2023), Journal for immunotherapy of cancer, 11

STAT3/LKB1 controls metastatic prostate cancer by regulating mTORC1/CREB pathway.

Journal article

Pencik J. et al, (2023), Molecular cancer, 22

Visualising tapasin- and TAPBPR-assisted editing of major histocompatibility complex class-I immunopeptidomes.

Journal article

van Hateren A. and Elliott T., (2023), Current opinion in immunology, 83

Load More